UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2013-05, Vol.40 (5), p.800-816

2013

Volltextzugriff (PDF)

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2014-02, Vol.41 (2), p.214-222

2014

Volltextzugriff (PDF)

Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma

The quarterly journal of nuclear medicine and molecular imaging, 2008-12, Vol.52 (4), p.334

2008

Volltextzugriff (PDF)

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2014-03, Vol.41 (3), p.584-584

2014

Volltextzugriff (PDF)

DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy

European Journal of Nuclear Medicine, 1997-07, Vol.24 (7), p.792-795

1997

Volltextzugriff (PDF)

Yttrium-90-labelled somatostatin-analogue for cancer treatment

The Lancet (British edition), 1998-02, Vol.351 (9100), p.417-418

1998

Volltextzugriff (PDF)

A comparison of In-111-DOTATOC and In-111-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2004-09, Vol.31 (9), p.1257

2004

Volltextzugriff (PDF)

Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism

Thrombosis and haemostasis, 2001-01, Vol.85 (1), p.42-46

2001

Volltextzugriff (PDF)

Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab

The quarterly journal of nuclear medicine and molecular imaging, 2012-12, Vol.56 (6), p.544

2012

Volltextzugriff (PDF)

Use of pro-atrial natriuretic peptide in the detection of myocardial ischaemia

European journal of clinical investigation, 2005-07, Vol.35 (7), p.450-456

2005

Volltextzugriff (PDF)

PET and SPECT in whiplash syndrome: a new approach to a forgotten brain?

Journal of neurology, neurosurgery and psychiatry, 1997-09, Vol.63 (3), p.368-372

1997

Volltextzugriff (PDF)

Successful Targeted Radiotherapy with Y-DOTATOC in a Patient with Merkel Cell Carcinoma: A Case Report

Oncology, 2004-02, Vol.66 (2), p.160

2004

Volltextzugriff (PDF)

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

The Journal of nuclear medicine (1978), 2005-01, Vol.46 (1 suppl), p.62S

2005

Volltextzugriff (PDF)

Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2005-04, Vol.32 (4), p.511-512

2005

Volltextzugriff (PDF)

Liver transplantation for patients with metastatic endocrine tumors: Single‐center experience with 15 patients

Liver transplantation, 2006-07, Vol.12 (7), p.1089-1096

2006

Volltextzugriff (PDF)

Comparing monoclonal antibodies and small peptidic hormones for local targeting of malignant gliomas

Acta neurochirurgica. Supplement, 2003, Vol.88, p.83

2003

Volltextzugriff (PDF)

Brain SPECT findings in late whiplash syndrome

The Lancet (British edition), 1995-06, Vol.345 (8963), p.1513-1514

1995

Volltextzugriff (PDF)

A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2004-09, Vol.31 (9), p.1257

2004

Volltextzugriff (PDF)

Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting

Journal of the American College of Cardiology, 2003-07, Vol.42 (1), p.33-40

2003

Volltextzugriff (PDF)

Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study

European Journal of Nuclear Medicine, 1997-07, Vol.24 (7), p.787-791

1997

Volltextzugriff (PDF)

A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapy

American journal of kidney diseases, 2001-04, Vol.37 (4), p.847-851

2001

Volltextzugriff (PDF)

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study

Annals of oncology, 2001-07, Vol.12 (7), p.941-945

2001

Volltextzugriff (PDF)

Functional brain imaging in 200 patients after whiplash injury

The Journal of nuclear medicine (1978), 1997-06, Vol.38 (6), p.1002-1002

1997

Volltextzugriff (PDF)

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

European journal of nuclear medicine and molecular imaging, 2002-04, Vol.29 (4), p.486-493

2002

Volltextzugriff (PDF)

Successful diffusible brachytherapy (dBT) of a progressive low-grade astrocytoma using the locally injected peptidic vector and somatostatin analogue [90Y] - DOTA 0-D-Phe 1-Tyr 3-octreotide (DOTATOC)

Swiss medical weekly, 2001-11

2001

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(89)
Deutsch
(20)

Erscheinungsjahr

n.n

Thema

Humans
(69)
Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Male
(49)
Female
(44)
Middle Aged
(44)
Adult
(32)
Aged
(32)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Radiology, Nuclear Medicine & Medical Imaging
(22)
Octreotide - Analogs & Derivatives
(15)
Radionuclide Imaging
(15)
Octreotide - Therapeutic Use
(14)
Radiopharmaceuticals - Therapeutic Use
(13)
Tomography, Emission-Computed, Single-Photon
(13)
Cardiovascular System & Cardiology
(12)
Cardiac & Cardiovascular Systems
(11)
Treatment Outcome
(10)
Aged, 80 And Over
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy

Yttrium-90-labelled somatostatin-analogue for cancer treatment

A comparison of In-111-DOTATOC and In-111-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism

Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab

Use of pro-atrial natriuretic peptide in the detection of myocardial ischaemia

PET and SPECT in whiplash syndrome: a new approach to a forgotten brain?

Successful Targeted Radiotherapy with Y-DOTATOC in a Patient with Merkel Cell Carcinoma: A Case Report

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours

Liver transplantation for patients with metastatic endocrine tumors: Single‐center experience with 15 patients

Comparing monoclonal antibodies and small peptidic hormones for local targeting of malignant gliomas

Brain SPECT findings in late whiplash syndrome

A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting

Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study

A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapy

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study

Functional brain imaging in 200 patients after whiplash injury

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

Successful diffusible brachytherapy (dBT) of a progressive low-grade astrocytoma using the locally injected peptidic vector and somatostatin analogue [90Y] - DOTA 0-D-Phe 1-Tyr 3-octreotide (DOTATOC)

Suchergebnisse filtern